Decongestant Market
Description
Decongestant Market, By Type of Decongestant (Oral Decongestants, Nasal Decongestants:), By Formulation (Tablets, Capsules, Syrups, Nasal Sprays, Drops, Inhalers), By Mode of Action (Alpha-Adrenergic Agonists, Vasoconstrictors, Others), By Application (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Sinusitis, Nasal Congestion, Cold and Flu, Others, By Distribution Channel (Over-the-Counter (OTC) Sales, Prescription-based Sales), By Age Group (Pediatric Population, Adult Population), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
A decongestant is a medicine which relieves nasal congestion and helps someone who has a cold to breathe more easily. Decongestants help ease a blocked or a stuffy nose and provide short-term relief for a blocked or a stuffy nose (nasal congestion). They work by reducing the swelling of the blood vessels in the nose. Decongestant nasal drops relieve the breathing problems caused by colds and flu. Tablets or nose drops containing a decongestant can be used to treat blocked noses. This helps to open up the airways. Thus, there is an increase in demand for decongestants worldwide.
Market Dynamics:
Increasing incidence of seasonal and perennial allergic rhinitis, rising prevalence of sinusitis, rise in demand for safe and effective decongestants (tablets, capsules, syrups, nasal sprays, drops, and inhalers, growing geriatric population, and introduction of novel products in the market are major factors expected to propel growth of the global decongestant market.
For instance, in June 2021, the Food & Drug Administration (FDA) approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch. FDA approved Astepro (azelastine hydrochloride nasal spray, 0.15%) for seasonal and perennial allergic rhinitis for adults and children six years of age and older.
Moreover, in July 2022, Dr Reddy's Laboratories launched an over-the-counter generic medication for relief from both nasal and sinus congestion due to colds or allergies. The company also launch Fexofenadine HCI 180mg and Pseudoephedrine HCI 240mg extended release tables in the U.S.
Key features of the study:
This report provides in-depth analysis of the global decongestant market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global decongestant market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Mylan N.V., Church & Dwight Co., Inc., Perrigo Company plc, Procter & Gamble Co., Bayer AG, Sanofi S.A., Novartis AG, GlaxoSmithKline plc, Pfizer Inc., Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Prestige Consumer Healthcare Inc., Reckitt Benckiser Group plc, and Sandoz International GmbH (Novartis subsidiary), among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global decongestant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global decongestant market.
Detailed Segmentation:
By Type of Decongestant:
Oral Decongestants:
Pseudoephedrine
Phenylephrine
Others
Nasal Decongestants:
Oxymetazoline
Xylometazoline
Phenylephrine
Naphazoline
Others
By Formulation:
Tablets
Capsules
Syrups
Nasal Sprays
Drops
Inhalers
By Mode of Action:
Alpha-Adrenergic Agonists
Vasoconstrictors
Others
By Application:
Seasonal Allergic Rhinitis
Perennial Allergic Rhinitis
Sinusitis
Nasal Congestion
Cold and Flu
Others
By Distribution Channel:
Over-the-Counter (OTC) Sales
Prescription-based Sales
By Age Group:
Pediatric Population
Adult Population
By Region:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Company Profiles:
Mylan N.V.
Church & Dwight Co., Inc.
Perrigo Company plc
Procter & Gamble Co.
Bayer AG
Sanofi S.A.
Novartis AG
GlaxoSmithKline plc
Pfizer Inc.
Johnson & Johnson
Teva Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd.
Prestige Consumer Healthcare Inc.
Reckitt Benckiser Group plc
Sandoz International GmbH (Novartis subsidiary)
Table of Contents
147 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type of Decongestant
- Market Snapshot, By Formulation
- Market Snapshot, By Mode of Action
- Market Snapshot, By Application
- Market Snapshot,, By Distribution Channel
- Market Snapshot,, By Age Group
- Market Snapshot,, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Growing burden of seasonal and perennial allergic rhinitis
- Product recalls and high use of generic drugs
- Increasing demand for safe and effective decongestants
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- 4. Decongestant Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
- 5. Decongestant Market, By Type of Decongestant, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Oral Decongestants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Pseudoephedrine
- Phenylephrine
- Others
- Nasal Decongestants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Oxymetazoline
- Xylometazoline
- Phenylephrine
- Naphazoline
- Others
- 6. Decongestant Market, By Formulation, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Syrups
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Nasal Sprays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- 7. Decongestant Market, By Mode of Action, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Alpha-Adrenergic Agonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Vasoconstrictors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- 8. Decongestant Market, By Application, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Seasonal Allergic Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Perennial Allergic Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Sinusitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Nasal Congestion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Cold and Flu
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- 9. Decongestant Market, By Distribution Channel, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Over-the-Counter (OTC) Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Prescription-based Sales
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- 10. Decongestant Market, By Age Group, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Pediatric Population
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Adult Population
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- 11. Decongestant Market, By Region, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2023-2030,(US$ Bn)
- 12. Competitive Landscape
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Church & Dwight Co., Inc.
- Perrigo Company plc
- Procter & Gamble Co.
- Bayer AG
- Sanofi S.A.
- Novartis AG
- GlaxoSmithKline plc
- Pfizer Inc.
- Johnson & Johnson
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Prestige Consumer Healthcare Inc.
- Reckitt Benckiser Group plc
- Sandoz International GmbH (Novartis subsidiary)
- Analyst Views
- 13. Section
- Research Methodology
- About us
- *Browse 24 market data tables and 28 figures on "Global Decongestant Market” - Europe forecast to 2030
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
